Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. (ARCT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARCT · as of Jun 8, 2026
Key Statistics
Explore Arcturus Therapeutics Holdings Inc. Data
arct stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 21 · Buy rate: 57.1%
The ARCT analyst consensus is Buy, based on ratings from 21 Wall Street analysts over the past 3 months. The average 12-month price target is $22.50, representing +212.93% upside from the current price of $7.19.
Competitors & Peers
arct competitorsARCT
ACHV
AVIR
FHTX
HUMA
IMRXStock Performance
Full HistoryAbout Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's develo…
what is arcturus therapeutics holdings inc. · arct stock overview · arcturus therapeutics holdings inc. company profile · who is arcturus therapeutics holdings inc. ceo · arct NASDAQ · arcturus therapeutics holdings inc. headquarters · arcturus therapeutics holdings inc. business segments
About Stock Overview & Key Data
Arcturus Therapeutics Holdings Inc. (ARCT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 22, 2013. As of the latest trading session, ARCT stock price is $7.19, with a market capitalization of $204.5M. The stock has returned -42.62% over the past 12 months and +17.37% year-to-date.
According to 21 Wall Street analysts, the consensus rating for Arcturus Therapeutics Holdings Inc. stock is Buy, with an average 12-month price target of $22.50. In fiscal year 2025, Arcturus Therapeutics Holdings Inc. reported revenue of $67.2M and net income of -$65.8M. For detailed data — including Arcturus Therapeutics Holdings Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Arcturus Therapeutics Holdings Inc. (ARCT) stock price is $7.19. The stock is traded on NASDAQ under the ticker symbol ARCT. The 52-week range is $5.85 – $24.17.